ECHELON-2: a large peripheral T-cell lymphoma trial

Bookmark and Share
Published: 2 Dec 2018
Views: 1496
Rating:
Save
Dr Owen O'Connor - Columbia University Medical Centre, New York, USA

Dr Owen O'Connor speaks to ecancer at ASH 2018 about the ECHELON-2 trial.

The ECHELON-2 trail tests brentuximab vedotin and CHP (A CHP) vs CHOP in the frontline treatment of patients with CD30 peripheral T-cell lymphomas.

Dr O'Connor describes the ways this large study was designed and run, and also details the results so far.

Watch his interview about the ACT-1 trial here.